Recent News

• 04.02.2025 - Denali Therapeutics Announces Initiation of BLA Filing for Accelerated Approval of Tividenofusp Alfa for the Treatment of Hunter Syndrome (MPS II) and Positive Ongoing Interactions with FDA on DNL126 Through START Program
• 04.02.2025 - Denali Therapeutics Announces Initiation of BLA Filing for Accelerated Approval of Tividenofusp Alfa for the Treatment of Hunter Syndrome (MPS II) and Positive Ongoing Interactions with FDA on DNL126 Through START Program
• 04.02.2025 - Denali Therapeutics Announces Initiation of BLA Filing for Accelerated Approval of Tividenofusp Alfa for the Treatment of Hunter Syndrome (MPS II) and Positive Ongoing Interactions with FDA on DNL126 Through START Program
• 03.18.2025 - March 18, 2025 2:30 PM PDT - March 18, 2025 2:55 PM PDT : Stifel CNS Days 2025
• 03.18.2025 - March 18, 2025 2:30 PM PDT - March 18, 2025 2:55 PM PDT : Stifel CNS Days 2025
• 03.17.2025 - March 17, 2025 9:00 AM PDT - March 17, 2025 9:30 AM PDT : UBS Virtual CNS Day 2025
• 03.17.2025 - March 17, 2025 9:00 AM PDT - March 17, 2025 9:30 AM PDT : UBS Virtual CNS Day 2025
• 03.10.2025 - March 10, 2025 1:40 PM PDT - March 4, 2025 2:10 PM PST : Leerink Partners Global Healthcare Conference
• 03.10.2025 - March 10, 2025 1:40 PM PDT - March 4, 2025 2:10 PM PST : Leerink Partners Global Healthcare Conference
• 03.04.2025 - March 4, 2025 3:10 PM PST - March 4, 2025 3:40 PM PST : TD Cowen 45th Annual Health Care Conference

Recent Filings

• 04.02.2025 - 8-K Current report
• 04.02.2025 - EX-99.1 EX-99.1
• 03.05.2025 - 8-K Current report
• 02.27.2025 - EX-99.1 EX-99.1
• 02.27.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 02.27.2025 - 8-K Current report